Source: PR Newswire

Press Release: Eli Lilly : Lilly to Participate in Evercore ISI 2nd Annual HealthCONx Conference

INDIANAPOLIS, Dec. 2, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the Evercore ISI 2nd Annual HealthCONx Conference on Wednesday, December 4, 2019. Daniel Skovronsky, M.D., Ph.D., Lilly's Chief Scientific Officer and President of Lilly Research Laboratories,...

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Based on data from Eli Lilly's latest SEC filings

Annual Revenue

Based on data from Eli Lilly's latest SEC filings

Employees

David A. Ricks's photo - Chairman & CEO of Eli Lilly

Chairman & CEO

David A. Ricks

CEO Approval Rating

60/100

Eli Lilly develops, produces and markets pharmaceutical products for health care professionals, patients and consumers.

E...
Read more